Capesize rates drag down by high tonnage list

Capesize rates spiraled downward due to high tonnage list that resulted weakness in the Pacific market. As such, the Capesize 5 time charter average dropped further by $1,834 day-on-day to $22,635 on Tuesday, after a steep sell off down the curve during late afternoon session. Following the decline, the Baltic Dry Index (BDI) slipped by …

FIS Fuel Oil Morning Report 22/07/2020

Brent futures tumbled 35 cents, or 0.8%, to $43.97 a barrel by 5:41 am GMT, and WTI futures plunged 39 cents, or 0.9%, to $41.53. Front-month September ICE Brent futures briefly touched a four-month high above $44.80/b in the US trading sessions as investor optimism was buoyed by promising results from multiple COVID-19 vaccine trials …

Capesize rates dip on subdued markets

Capesize rates reversed into losses after sluggish start to the week with little shipping activities. Thus, the Capesize 5 time charter average dropped by $616 day-on-day to $24,469 on Monday, due to the subdued Pacific and Atlantic market. The Baltic Dry Index (BDI) then followed the dip and slipped by 1.87% day-on-day to 1,678 readings …

DCE rebounds on Chinese fiscal stimulus

Iron ore futures opened low and closed on high on Tuesday, following market optimism on China’s demand despite rising supply from miners. The most-traded iron ore for September delivery on China’s Dalian Commodity Exchange rebounded from yesterday losses and gained by 2.75% or RMB 22.50 day-on-day to RMB 841 a tonne on July 21. Joining …

Oil Through the Looking Glass 21/7/20

Hedge Funds Pretty Flat on Oil Money managers seem to be staying clear of any new significant purchases of oil, or perhaps they have all taken a synchronised holiday, as purchases dropped to and equivalent 24 million bbls of futures and options, up slightly from 21 million the previous week, but still not really making …

FIS Fuel Oil Morning Report 21/07/2020

At 2:27 am GMT, Brent futures were up 7 cents/b, or 0.16%, at $43.35/b, while WTI was up by 6 cents/b, or 0.15%, at $40.87/b, and it has continued to rise into the European trading hours.   Prices were offered support by positive news on the development of vaccines as pharmaceuticals and medical institutions are …